Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 169

1.

Method development and validation of ursodiol and its major metabolites in human plasma by HPLC-tandem mass spectrometry.

Pinto MC, Berton DC, de Oliveira AC, Lazaro CM, Carandina SAC.

Clin Pharmacol. 2019 Jan 4;11:1-13. doi: 10.2147/CPAA.S187519. eCollection 2019.

2.

Correlation between measured and calculated free phenytoin serum concentration in neurointensive care patients with hypoalbuminemia.

Javadi SS, Mahjub R, Taher A, Mohammadi Y, Mehrpooya M.

Clin Pharmacol. 2018 Dec 13;10:183-190. doi: 10.2147/CPAA.S186322. eCollection 2018.

3.

Treatment of acne with a combination of propolis, tea tree oil, and Aloe vera compared to erythromycin cream: two double-blind investigations.

Mazzarello V, Donadu MG, Ferrari M, Piga G, Usai D, Zanetti S, Sotgiu MA.

Clin Pharmacol. 2018 Dec 13;10:175-181. doi: 10.2147/CPAA.S180474. eCollection 2018.

4.

Species difference in paclitaxel disposition correlated with poor pharmacological efficacy translation from mice to humans.

Li YF, Zhang C, Zhou S, He M, Zhang H, Chen N, Li F, Luan X, Pai M, Yuan H, Sun D, Li Y.

Clin Pharmacol. 2018 Nov 8;10:165-174. doi: 10.2147/CPAA.S185449. eCollection 2018.

5.

Evaluation of the single-dose pharmacokinetics and pharmacodynamics of apixaban in healthy Japanese and Caucasian subjects.

Frost C, Shenker A, Jhee S, Yu Z, Wang J, Bragat A, Pursley J, LaCreta F.

Clin Pharmacol. 2018 Oct 24;10:153-163. doi: 10.2147/CPAA.S169505. eCollection 2018.

6.

12-month effects of incretins versus SGLT2-Inhibitors on cognitive performance and metabolic profile. A randomized clinical trial in the elderly with Type-2 diabetes mellitus.

Perna S, Mainardi M, Astrone P, Gozzer C, Biava A, Bacchio R, Spadaccini D, Solerte SB, Rondanelli M.

Clin Pharmacol. 2018 Oct 9;10:141-151. doi: 10.2147/CPAA.S164785. eCollection 2018.

7.

The effect of combined treatment with sodium phenylbutyrate and cisplatin, erlotinib, or gefitinib on resistant NSCLC cells.

Al-Keilani MS, Alzoubi KH, Jaradat SA.

Clin Pharmacol. 2018 Oct 9;10:135-140. doi: 10.2147/CPAA.S174074. eCollection 2018.

8.

Mechanisms and the clinical relevance of complex drug-drug interactions.

Roberts AG, Gibbs ME.

Clin Pharmacol. 2018 Sep 27;10:123-134. doi: 10.2147/CPAA.S146115. eCollection 2018. Review.

9.

Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxin.

Oh F, Todhunter D, Taras E, Vallera DA, Borgatti A.

Clin Pharmacol. 2018 Sep 26;10:113-121. doi: 10.2147/CPAA.S160262. eCollection 2018.

10.

Pharmacokinetics of evocalcet in secondary hyperparathyroidism patients receiving hemodialysis: first-in-patient clinical trial in Japan.

Shigematsu T, Shimazaki R, Fukagawa M, Akizawa T.

Clin Pharmacol. 2018 Sep 11;10:101-111. doi: 10.2147/CPAA.S171044. eCollection 2018.

11.

A Phase I, open-label, randomized, crossover study in healthy subjects to evaluate the bioavailability of, and the food effect on, a pomalidomide oral liquid suspension.

Li Y, Liu L, Huang L, Wang X, Hoffmann M, Reyes J, Palmisano M, Zhou S.

Clin Pharmacol. 2018 Jul 19;10:89-99. doi: 10.2147/CPAA.S171735. eCollection 2018.

12.

Safety and neutralizing rabies antibody in healthy subjects given a single dose of rabies immune globulin caprylate/chromatography purified.

Hanna K, Cruz MC, Mondou E, Corsi E, Vandeberg P.

Clin Pharmacol. 2018 Jun 26;10:79-88. doi: 10.2147/CPAA.S166454. eCollection 2018.

13.

Pharmacokinetic evaluation of D-ribose after oral and intravenous administration to healthy rabbits.

Alzoubi KH, Ismail ZB, Al-Essa MK, Alshogran OY, Abutayeh RF, Abu-Baker N.

Clin Pharmacol. 2018 Jun 12;10:73-78. doi: 10.2147/CPAA.S167150. eCollection 2018.

14.

Erratum: A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban [Corrigendum.

[No authors listed]

Clin Pharmacol. 2018 Jun 11;10:71. doi: 10.2147/CPAA.S168295. eCollection 2018.

15.

Anti-factor Xa levels in obese patients receiving enoxaparin for treatment and prophylaxis indications.

Tahaineh L, Edaily SM, Gharaibeh SF.

Clin Pharmacol. 2018 May 18;10:63-70. doi: 10.2147/CPAA.S161599. eCollection 2018.

16.

Distribution of pomalidomide into semen of healthy male subjects after multiple doses.

Li Y, Wang X, Liu L, Reyes J, Palmisano M, Zhou S.

Clin Pharmacol. 2018 May 7;10:53-62. doi: 10.2147/CPAA.S167017. eCollection 2018.

17.

Pharmacokinetic equivalence study of nonsteroidal anti-inflammatory drug etoricoxib.

Tjandrawinata RR, Setiawati A, Nofiarny D, Susanto LW, Setiawati E.

Clin Pharmacol. 2018 Apr 6;10:43-51. doi: 10.2147/CPAA.S161024. eCollection 2018.

18.

Safinamide: an add-on treatment for managing Parkinson's disease.

Müller T.

Clin Pharmacol. 2018 Apr 5;10:31-41. doi: 10.2147/CPAA.S137740. eCollection 2018. Review.

19.

Pramlintide, an antidiabetic, is antineoplastic in colorectal cancer and synergizes with conventional chemotherapy.

Al-Keilani MS, Alsmadi DH, Darweesh RS, Alzoubi KH.

Clin Pharmacol. 2018 Mar 5;10:23-29. doi: 10.2147/CPAA.S153780. eCollection 2018.

20.

A review of the pharmacology and clinical efficacy of brivaracetam.

Klein P, Diaz A, Gasalla T, Whitesides J.

Clin Pharmacol. 2018 Jan 19;10:1-22. doi: 10.2147/CPAA.S114072. eCollection 2018. Review.

Supplemental Content

Loading ...
Support Center